Department of Gynecology and Obstetrics, International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China.
Chin Med J (Engl). 2019 Mar 5;132(5):505-511. doi: 10.1097/CM9.0000000000000051.
A correct thyroid function reference range is important for the accurate diagnosis of thyroid disease during pregnancy. However, there is no consensus on whether thyroid function reference ranges in Chinese population should follow the America Thyroid Association (ATA) guidelines. This study aimed to establish a thyroid function reference range more suited to the Chinese population by evaluating the current thyroid function reference range in pregnant Chinese women and comparing it to the ATA guidelines.
A total of 52,027 pregnant women were enrolled from January 2013 to December 2016. Thyroid stimulating hormone (TSH), free thyroxine (FT4), and thyroid peroxidase antibody (TPOAb) levels were tested during the first and third trimesters of pregnancy. Reference ranges of TSH and FT4 were established from the 2.5th and 97.5th percentiles of the TPOAb-negative population of women. The Mann-Whitney U test was used to compare thyroid hormones between the TPOAb-positive and TPOAb-negative groups.
We obtained that the TSH reference ranges were 0.03 to 3.52 mU/L and 0.39 to 3.67 mU/L, and the FT4 reference ranges were 11.7 to 19.7 pmol/L and 9.1 to 14.4 pmol/L, in the first and third trimester, respectively. If we used the 2011 ATA criteria about 7.0% and 4.0% pregnant women would be over diagnosed in first and third trimester, respectively, compared with local population thyroid hormone reference. When we compared our local criteria with the new 2017 ATA criteria, about 1.2% and 0.8% pregnant women would have a missed diagnosis in first and third trimester, respectively.
Based on our data, which is in line with the current ATA guidelines, a population-based thyroid function reference range would be the first choice for diagnosis of thyroid disease during pregnancy in China. In case such population-based thyroid function reference ranges are unavailable in the east of China, our reference ranges can be adopted, if the same assay is used.
www.chictr.org.cn (No. ChiCTR1800014394).
准确的甲状腺功能参考范围对于妊娠期甲状腺疾病的准确诊断非常重要。然而,对于中国人的甲状腺功能参考范围是否应遵循美国甲状腺协会(ATA)指南尚无共识。本研究旨在通过评估当前中国孕妇的甲状腺功能参考范围,并与 ATA 指南进行比较,建立更适合中国人的甲状腺功能参考范围。
2013 年 1 月至 2016 年 12 月,共纳入 52027 名孕妇。在妊娠第 1 和第 3 个三个月期间检测促甲状腺激素(TSH)、游离甲状腺素(FT4)和甲状腺过氧化物酶抗体(TPOAb)水平。从 TPOAb 阴性的女性中,使用第 2.5 个和第 97.5 个百分位数建立 TSH 和 FT4 的参考范围。使用 Mann-Whitney U 检验比较 TPOAb 阳性和 TPOAb 阴性组之间的甲状腺激素。
我们发现 TSH 的参考范围分别为 0.03 至 3.52 mU/L 和 0.39 至 3.67 mU/L,FT4 的参考范围分别为 11.7 至 19.7 pmol/L 和 9.1 至 14.4 pmol/L,分别在妊娠第 1 和第 3 个三个月。如果我们使用 2011 年 ATA 标准,与当地人群的甲状腺激素参考值相比,分别有 7.0%和 4.0%的孕妇在第 1 和第 3 个三个月会被过度诊断。当我们将我们的本地标准与新的 2017 ATA 标准进行比较时,分别有 1.2%和 0.8%的孕妇在第 1 和第 3 个三个月会被漏诊。
基于我们的数据,与当前的 ATA 指南一致,基于人群的甲状腺功能参考范围将是中国妊娠期甲状腺疾病诊断的首选。如果在中国东部地区没有基于人群的甲状腺功能参考范围,可以采用我们的参考范围,如果使用相同的检测方法。